biomed devic servic
make look easi strong support lofti
bottom line reiter buy rate follow result came
cg/street expect specif sale y/i
organ cg/street estim strength
driven momentum across entir portfolio particularli knees/mako
instrument spine oper adj ep beat cg/consensu
reflect strong sale growth combin oper expens improv
adj om came slightli estim
net-net continu view compel asset large-cap med-tech
believ core posit growth-ori investor given view
stable/improv market fundament robust new product cycl opportun
durabl oper leverag thesi deliv upsid guidanc remain
intact compani continu take market share across board benefit
meaning halo effect mako placement improv capit equip
market someth expect continue/acceler note underli
new product cycl medsurg neurotech/spin support fundament
momentum across market buy pt
revenu detail report sale growth organ
support us sale growth organ intern sale
growth xfx organ orthoped grew xfx strong
perform knee xfx offset weak ou trauma/
extrem xfx medsurg saw continu stellar growth
xfx driven on-going strength instrument xfx
support build-out special sale forc endoscopi
xfx neurotech spine also strong post xfx growth
driven continu strong demand stroke earli contribut
acquisit manag continu guid msd pro forma growth spine
guidanc rais guidanc organ sale growth
previous despit strong continu see opportun
upsid given on-going momentum across us ortho medsurg neurotech/spin
heel new product launch well continu mako adopt strong
market backdrop capit equip ep guidanc also rais
mako place mako system ww prior year includ
system place us mako procedur exceed total knee
procedur exceed y/i also note manag repeatedli
mention yet seen impact competit robot launch
previou year though look detail competitor yet report
lastli note place mako ortho hospit
yet meaning enter key asian market like china japan demonstr
earli natur opportun potenti continu momentum beyond
earli clinic data begin trickl
price close busi juli
develop manufactur market devic
instrument orthoped
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
updat full-year organ revenu growth guidanc rang
full-year adjust ep expect
rang previous adjust
ep expect rang fx impact expect
nomin headwind full year bottom-lin
perspect manag note fx neg impact ep
updat full year guidanc headwind previous
chang estim
made follow chang estim
figur chang estim
large-cap medic devic comp group trade mean price-to-earnings multipl
increas price target price target util
multipl appli pro forma ep estim
figur matrix discount rate impli share price target
buy unchang target price juli
biomed devic servic
except ep newold newold newold revenu oper net pe multipl price metric use price-to-earnings valuat analysisbroad large-cap medic devic price-to-earnings multipl forma
stryker
one world lead medic technolog compani
broadly-bas rang product orthoped signific presenc
medic specialti compani product includ implant use joint
replac trauma spinal surgeri surgic equip surgic
navig system endoscop commun system patient handl
emerg medic equip medic devic product use varieti
buy unchang target price juli
biomed devic servic
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
buy unchang target price juli
biomed devic servic
stryker corpor quarterli incom statementcanaccord genuiti kyle except per share good technolog special oper ex chg oper ex chg erest incom incom incom ex one-tim chg incom ex one-tim ep ex one-tim chg ep ex acq relat gross oper ex chg oper ex chg ex net charg net ex one-tim growth oper net incom charg ep charg ep ex acq growth net incom charg ep charg ep ex acq
buy unchang target price juli
biomed devic servic
stryker corpor revenu mixcanaccord genuiti kyle mix us y/i y/i xfx/x q/q q/q mixdomest stryker
